Dyne Therapeutics (DYN) Q3 2026 Earnings

29JulConfirmed
Q3 2025
Q4 2025
Q2 2026
Q3 2026
-1.08
-0.96
-0.85
-0.73

Details

Expected EPS
-0.748777
Actual EPS
-1.08
Surprise EPS
-0.33
Surprise Percent
+44.24%

Description

Dyne Therapeutics (DYN) has reported earnings of -1.08 per share for Q3 2026.

0 Comments

Share your thoughts